Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Importance of the Topic

Adequate quantification of adrenal steroids like 17-hydroxyprogesterone (17-OHP), androstenedione (A4) and cortisol is critical in clinical research assessing adrenal function and congenital adrenal hyperplasia. Traditional immunoassays often suffer from antibody cross-reactivity, leading to inaccurate results. Ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) overcomes these limitations, offering high selectivity, sensitivity and throughput.

Objectives and Study Overview

The study aimed to develop and validate a rapid, sensitive UPLC-MS/MS method for simultaneous measurement of 17-OHP, A4 and cortisol in limited-volume human serum samples. Key goals included minimizing sample preparation steps, achieving chromatographic resolution of isobaric steroids and meeting regulatory performance criteria for sensitivity, linearity and precision.

Methodology

Sample preparation involved single liquid–liquid extraction of 50 µL serum with methyl-tert-butyl ether, evaporation and reconstitution in aqueous methanol. Chromatographic separation used an ACQUITY UPLC HSS T3 column (2.1 × 50 mm, 1.8 µm) with a binary gradient of ammonium acetate/formic acid in water (phase A) and methanol (phase B). A 4.5 min run time with a 600 µL/min flow rate provided baseline separation of target steroids and isobaric interferents. MS/MS detection was performed on a Xevo TQ MS in positive electrospray mode, using multiple reaction monitoring with optimized cone voltages and collision energies for quantifier and qualifier transitions.

Used Instrumentation

• ACQUITY UPLC System with HSS T3 column and VanGuard pre-column
• Xevo TQ MS triple quadrupole mass spectrometer
• TruView maximum recovery vials
• MassLynx Software with TargetLynx Application Manager

Main Results and Discussion

The method achieved limits of detection and quantification of 0.25 and 0.5 ng/mL for all analytes, respectively. Calibration curves were linear up to 300 ng/mL for 17-OHP (r2 > 0.998), 500 ng/mL for cortisol and 200 ng/mL for A4 (r2 > 0.997). Within- and between-batch precision showed coefficients of variation below 10% across quality-control levels. Recovery exceeded 70% for all steroids, and matrix suppression (10–50%) was effectively compensated by stable isotope-labeled internal standards. Chromatographic resolution separated isobaric steroids (11-deoxycortisol, corticosterone, 21-deoxycortisol), ensuring analytical selectivity.

Benefits and Practical Applications

• Minimal sample volume and simple extraction streamline workflow
• No derivatization required, reducing complexity
• Fast 4.5 min analysis compatible with high-throughput labs
• Robust quantification supports clinical research and therapeutic monitoring

Future Trends and Applications

Advances may include multiplex panels covering broader steroid profiles, integration with automated sample preparation systems, use of high-resolution MS for additional specificity and miniaturized extraction techniques. Standardization of UPLC-MS/MS assays across laboratories will facilitate comparability of clinical data and support personalized medicine approaches.

Conclusion

The validated UPLC-MS/MS method delivers rapid, sensitive and selective measurement of key adrenal steroids in limited-volume serum samples. Its performance meets regulatory guidelines and addresses common immunoassay limitations, making it a valuable tool for clinical research into adrenal disorders.

References

1. Guidance for Industry for Bioanalytical Method Validation. U.S. Department of Health and Human Services, FDA, 2001.